
JAN 2011
2010 Immunotherapy Update
J Allergy Clin Immunol . 2011 Jan;127(1 Suppl):S1-55.
Linda Cox, Harold Nelson, Richard Lockey, Christopher Calabria, Thomas Chacko, Ira Finegold, Michael Nelson, Richard Weber, David I Bernstein, Joann Blessing-Moore, David A Khan, David M Lang, Richard A Nicklas, John Oppenheimer, Jay M Portnoy, Christopher Randolph, Diane E Schuller, Sheldon L Spector, Stephen Tilles, Dana Wallace
Abstract
These parameters were developed by the Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma & Immunology (AAAAI); the American College of Allergy, Asthma & Immunology (ACAAI); and the Joint Council of Allergy, Asthma & Immunology. The American Academy of Allergy, Asthma & Immunology and the American College of Allergy, Asthma & Immunology have jointly accepted responsibility for establishing “Allergen immunotherapy: A practice parameter third update.” This is a complete and comprehensive document at the current time. The medical environment is a changing environment, and not all recommendations will be appropriate for all patients. Because this document incorporated the efforts of many participants, no single individual, including those who served on the Joint Task Force, is authorized to provide an official AAAAI or ACAAI interpretation of these practice parameters. Any request for information about or an interpretation of these practice parameters by the AAAAI or the ACAAI should be directed to the Executive Offices of the AAAAI, the ACAAI, and the Joint Council of Allergy, Asthma & Immunology. These parameters are not designed for use by pharmaceutical companies in drug promotion. A current list of published practice parameters of the Joint Task Force on Practice Parameters for Allergy and Immunology can be found in Table E1 in this article’s Online Repository at www.jacionline.org.
Click Below to Read the Full Publication